Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
O Biologico
|
October 29, 2010
Herbicides
A O MARTINS, H S LEPAGE
Virologica Sinica
|
February 7, 2013
Characterization of a putative filovirus vaccine: virus-like particles
Karen A O Martins, Travis K Warren, Sina Bavari
Vaccine
|
June 20, 2016
Considerations for the development of Zika virus vaccines
K A O Martins, J M Dye, S Bavari
Expert Review of Vaccines
|
October 14, 2014
Vaccine adjuvant uses of poly-IC and derivatives
Karen A O Martins, Sina Bavari, Andres M Salazar
Environmental Technology
|
September 16, 2004
Use of chitosan microspheres as remedial material for acidity and iron (III) contents of coal mining wastewaters
V T Fávere, R Laus, M C M Laranjeira, et al.
Expert Review of Anti-Infective Therapy
|
December 7, 2017
Treatment-focused Ebola trials, supportive care and future of filovirus care
Maryam Keshtkar-Jahromi, Karen A O Martins, Anthony P Cardile, et al.
Journal of Translational Medicine
|
July 16, 2015
A thermostable, chromatographically purified Ebola nano-VLP vaccine
John H Carra, Karen A O Martins, Rowena D Schokman, et al.
Vaccine
|
June 9, 2019
Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
Melek M E Sunay, Karen A O Martins, Jesse T Steffens, et al.
Clinical Proteomics
|
September 7, 2016
Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations
Lisa H Cazares, Michael D Ward, Ernst E Brueggemann, et al.
Plos One
|
March 4, 2014
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation
Karen A O Martins, Jesse T Steffens, Sean A van Tongeren, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
O Biologico
|
October 29, 2010
Herbicides
A O MARTINS, H S LEPAGE
Virologica Sinica
|
February 7, 2013
Characterization of a putative filovirus vaccine: virus-like particles
Karen A O Martins, Travis K Warren, Sina Bavari
Vaccine
|
June 20, 2016
Considerations for the development of Zika virus vaccines
K A O Martins, J M Dye, S Bavari
Expert Review of Vaccines
|
October 14, 2014
Vaccine adjuvant uses of poly-IC and derivatives
Karen A O Martins, Sina Bavari, Andres M Salazar
Environmental Technology
|
September 16, 2004
Use of chitosan microspheres as remedial material for acidity and iron (III) contents of coal mining wastewaters
V T Fávere, R Laus, M C M Laranjeira, et al.
Expert Review of Anti-Infective Therapy
|
December 7, 2017
Treatment-focused Ebola trials, supportive care and future of filovirus care
Maryam Keshtkar-Jahromi, Karen A O Martins, Anthony P Cardile, et al.
Journal of Translational Medicine
|
July 16, 2015
A thermostable, chromatographically purified Ebola nano-VLP vaccine
John H Carra, Karen A O Martins, Rowena D Schokman, et al.
Vaccine
|
June 9, 2019
Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
Melek M E Sunay, Karen A O Martins, Jesse T Steffens, et al.
Clinical Proteomics
|
September 7, 2016
Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations
Lisa H Cazares, Michael D Ward, Ernst E Brueggemann, et al.
Plos One
|
March 4, 2014
Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation
Karen A O Martins, Jesse T Steffens, Sean A van Tongeren, et al.
Page
of 2